Table 3.
Serum Concentrations of Reproductive Hormones at Baseline and Follow-Up Visits 5 and 10 in the Study of Women's Health Across the Nation
| Characteristics | Baseline | Visit 5a | Visit 10a |
|---|---|---|---|
| n | 3266 | 1628 | 1703 |
| T, ng/dL | 41.5 (26.4) | 35.8 (21.1) | 40.2 (27.1) |
| FSH, mIU/mL | 15.9 (15.6) | 41.45 (68.7) | 108.55 (68.7) |
| E2, pg/mL | 55.2 (55.35) | 25.43 (45.8) | 17.35 (10.95) |
| DHEAS, μg/dL | 114.15 (95) | 113.65 (92.85) | 107.1 (90.7) |
| SHBG, nm | 40.9 (29.4) | 40.5 (32.15) | 39.1 (33.4) |
Data are expressed as median (interquartile range).
a
Women reporting hormone therapy at a follow-up visit were excluded.